Hyperfine (HYPR) vs Integer (ITGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Integer (ITGR) has outperformed Hyperfine (HYPR) over the past year, gaining 22.0% versus a loss of 50.6%. Over five years, ITGR leads with a +41.8% price change compared with -91.5% for HYPR. Integer is the larger company by market cap ($4.31 billion vs $99.7 million), about 43.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYPR | ITGR |
|---|---|---|
| Share price | $0.9401 | $126.65 |
| Market cap | $99.70M | $4.31B |
| 1-day change | +10.73% | +0.05% |
| YTD return | -13.28% | +61.41% |
| 1-year return | -50.64% | +22.05% |
| 5-year return | -91.46% | +41.79% |
| P/E ratio (TTM) | — | 34.60 |
| Forward P/E | — | 18.44 |
| EPS (TTM) | $-0.37 | $3.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.85B |
| Revenue growth (YoY) | — | +7.98% |
| Net income (latest FY) | — | $102.81M |
| Gross margin | — | 26.99% |
| Operating margin | — | 11.94% |
| Net margin | — | 5.55% |
| 52-week high | $2.22 | $126.80 |
| 52-week low | $0.754 | $62.00 |
| Distance from 52-week high | -57.65% | -0.12% |
| Analyst consensus | — | none |
| Avg. price target upside | — | -3.83% |
| Average volume | 611.89K | 981.56K |
| Shares outstanding | 90.99M | 34.00M |
| Employees | — | 11,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Integer is about 43.2 times larger than Hyperfine by market value ($4.31B vs $99.70M).
- ITGR has outperformed HYPR by 72.7 percentage points over the past year.
About Integer
ITGR stock →Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 11,000 employees
HYPR vs ITGR FAQ
Which is bigger, Hyperfine or Integer?
Integer (ITGR) is larger, with a market capitalization of $4.31B compared with $99.70M for Hyperfine (HYPR).
Which stock has performed better over the past year, HYPR or ITGR?
ITGR returned +22.05% over the past 12 months, compared with -50.64% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are Hyperfine and Integer in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.